BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 23299917)

  • 1. New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants.
    Andreasen C; Nielsen JB; Refsgaard L; Holst AG; Christensen AH; Andreasen L; Sajadieh A; Haunsø S; Svendsen JH; Olesen MS
    Eur J Hum Genet; 2013 Sep; 21(9):918-28. PubMed ID: 23299917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Disease Expression of Pathogenic and Likely Pathogenic Variants Associated With Inherited Cardiomyopathies in the General Population.
    Bourfiss M; van Vugt M; Alasiri AI; Ruijsink B; van Setten J; Schmidt AF; Dooijes D; Puyol-Antón E; Velthuis BK; van Tintelen JP; Te Riele ASJM; Baas AF; Asselbergs FW
    Circ Genom Precis Med; 2022 Dec; 15(6):e003704. PubMed ID: 36264615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.
    Waldmüller S; Schroeder C; Sturm M; Scheffold T; Imbrich K; Junker S; Frische C; Hofbeck M; Bauer P; Bonin M; Gawaz M; Gramlich M
    Mol Cell Probes; 2015 Oct; 29(5):308-14. PubMed ID: 25979592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of genetic variants previously associated with LQT syndrome in new exome data.
    Refsgaard L; Holst AG; Sadjadieh G; Haunsø S; Nielsen JB; Olesen MS
    Eur J Hum Genet; 2012 Aug; 20(8):905-8. PubMed ID: 22378279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted next-generation sequencing detects novel gene-phenotype associations and expands the mutational spectrum in cardiomyopathies.
    Forleo C; D'Erchia AM; Sorrentino S; Manzari C; Chiara M; Iacoviello M; Guaricci AI; De Santis D; Musci RL; La Spada A; Marangelli V; Pesole G; Favale S
    PLoS One; 2017; 12(7):e0181842. PubMed ID: 28750076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia.
    Jabbari J; Jabbari R; Nielsen MW; Holst AG; Nielsen JB; Haunsø S; Tfelt-Hansen J; Svendsen JH; Olesen MS
    Circ Cardiovasc Genet; 2013 Oct; 6(5):481-9. PubMed ID: 24025405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac structural and sarcomere genes associated with cardiomyopathy exhibit marked intolerance of genetic variation.
    Pan S; Caleshu CA; Dunn KE; Foti MJ; Moran MK; Soyinka O; Ashley EA
    Circ Cardiovasc Genet; 2012 Dec; 5(6):602-10. PubMed ID: 23074333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Cadherin 2 (
    Mayosi BM; Fish M; Shaboodien G; Mastantuono E; Kraus S; Wieland T; Kotta MC; Chin A; Laing N; Ntusi NB; Chong M; Horsfall C; Pimstone SN; Gentilini D; Parati G; Strom TM; Meitinger T; Pare G; Schwartz PJ; Crotti L
    Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28280076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Insights from Consanguineous Cardiomyopathy Families.
    Maurer C; Boleti O; Najarzadeh Torbati P; Norouzi F; Fowler ANR; Minaee S; Salih KH; Taherpour M; Birjandi H; Alizadeh B; Salih AF; Bijari M; Houlden H; Pittman AM; Maroofian R; Almashham YH; Karimiani EG; Kaski JP; Faqeih EA; Vakilian F; Jamshidi Y
    Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome data clouds the pathogenicity of genetic variants in Pulmonary Arterial Hypertension.
    Abbasi Y; Jabbari J; Jabbari R; Glinge C; Izadyar SB; Spiekerkoetter E; Zamanian RT; Carlsen J; Tfelt-Hansen J
    Mol Genet Genomic Med; 2018 Sep; 6(5):835-844. PubMed ID: 30084161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combinatorial oligogenic basis for the phenotypic plasticity between late-onset dilated and arrhythmogenic cardiomyopathy in a single family.
    Pourebrahim K; Marian JG; Tan Y; Chang JT; Marian AJ
    J Cardiovasc Aging; 2021; 1():. PubMed ID: 34790974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyses of more than 60,000 exomes questions the role of numerous genes previously associated with dilated cardiomyopathy.
    Nouhravesh N; Ahlberg G; Ghouse J; Andreasen C; Svendsen JH; Haunsø S; Bundgaard H; Weeke PE; Olesen MS
    Mol Genet Genomic Med; 2016 Nov; 4(6):617-623. PubMed ID: 27896284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Relevance of the Systematic Analysis of Copy Number Variants in the Genetic Study of Cardiomyopathies.
    de Uña-Iglesias D; Ochoa JP; Monserrat L; Barriales-Villa R
    Genes (Basel); 2024 Jun; 15(6):. PubMed ID: 38927710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic cardiomyopathies.
    Wilcox JE; Hershberger RE
    Curr Opin Cardiol; 2018 May; 33(3):354-362. PubMed ID: 29561320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy.
    Kübler J; Burgstahler C; Brendel JM; Gassenmaier S; Hagen F; Klingel K; Olthof SC; Blume K; Wolfarth B; Mueller KAL; Greulich S; Krumm P
    Int J Cardiovasc Imaging; 2021 Aug; 37(8):2501-2515. PubMed ID: 34019206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpreting secondary cardiac disease variants in an exome cohort.
    Ng D; Johnston JJ; Teer JK; Singh LN; Peller LC; Wynter JS; Lewis KL; Cooper DN; Stenson PD; Mullikin JC; Biesecker LG;
    Circ Cardiovasc Genet; 2013 Aug; 6(4):337-46. PubMed ID: 23861362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New population-based exome data question the pathogenicity of some genetic variants previously associated with Marfan syndrome.
    Yang RQ; Jabbari J; Cheng XS; Jabbari R; Nielsen JB; Risgaard B; Chen X; Sajadieh A; Haunsø S; Svendsen JH; Olesen MS; Tfelt-Hansen J
    BMC Genet; 2014 Jun; 15():74. PubMed ID: 24941995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of pathogenic and likely pathogenic variants in the RASopathy genes in patients who have had panel testing for cardiomyopathy.
    Aljeaid D; Sanchez AI; Wakefield E; Chadwell SE; Moore N; Prada CE; Zhang W
    Am J Med Genet A; 2019 Apr; 179(4):608-614. PubMed ID: 30762279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study.
    Brownrigg JR; Leo V; Rose J; Low E; Richards S; Carr-White G; Elliott PM
    Heart; 2022 Aug; 108(17):1383-1391. PubMed ID: 34969871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FLNC pathogenic variants in patients with cardiomyopathies: Prevalence and genotype-phenotype correlations.
    Ader F; De Groote P; Réant P; Rooryck-Thambo C; Dupin-Deguine D; Rambaud C; Khraiche D; Perret C; Pruny JF; Mathieu-Dramard M; Gérard M; Troadec Y; Gouya L; Jeunemaitre X; Van Maldergem L; Hagège A; Villard E; Charron P; Richard P
    Clin Genet; 2019 Oct; 96(4):317-329. PubMed ID: 31245841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.